Curative Biotechnology, Inc. (CUBTD)
OTCMKTS · Delayed Price · Currency is USD
1.100
-0.100 (-8.33%)
At close: Apr 2, 2026
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $7.87 million as of April 2, 2026. Its market cap has decreased by -41.38% in one year.
Market Cap
7.87M
Enterprise Value
11.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.10
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.35M to 7.87M, a decrease of -64.80%. That is a compound annual growth rate of -5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 7.87M | 35.80% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 10.48M |
| NKGen Biotech | 7.84M |
| BetterLife Pharma | 7.54M |
| TRON Group | 7.45M |
| Nymox Pharmaceutical | 7.35M |
| Synlogic | 6.96M |
| Orgenesis | 5.90M |
| Bioxytran | 5.63M |